Three health professionals in Norway who recently received the AstraZeneca vaccine against COVID-19 are being treated at the hospital for bleeding, blood clots and low platelet counts, Norwegian health officials said on Saturday. following a similar movement in Denmark. Iceland later did the same. “We don’t know if the cases are related to the vaccine,” said Sigurd Hortemo, a senior doctor at the Norwegian Medicines Agency, at a news conference held in conjunction with the Norwegian Institute of Public Health. The European drug regulatory agency, EMA, would investigate the three incidents, Hortemo added. “They have very unusual symptoms: bleeding, blood clots and low platelet counts,” said Steinar Madsen, Medical Director of the Norwegian Medicines Agency “They are very sick … We take this very seriously,” he said, adding that authorities received notification of cases on Saturday.
cnxps.cmd.push (function () {cnxps ({playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’}). render (‘4c4d856e0e6f4e3d808bbc1715e132f6’);});
if (window.location.pathname.indexOf (“656089”)! = -1) {console.log (“hedva connatix”); document.getElementsByClassName (“divConnatix”)[0].style.display = “none”;}AstraZeneca was not immediately available for comment. Before the move from Denmark and Norway, Austria stopped using a batch of AstraZeneca vaccines while investigating a death from coagulation disorders and a disease from pulmonary embolism. Still, the EMA said on Thursday that the vaccine’s benefits outweighed its risks and could continue to be administered. Europe is struggling to accelerate the launch of a vaccine after delays in the delivery of Pfizer and AstraZeneca, despite an increase in cases amid a more contagious virus variant that has triggered new blockages in countries like Italy and France.